Abstract S4-07: BELLE-3: a phase III study of buparlisib+ fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic …
user-5f8cf7e04c775ec6fa691c92（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要